// App-Quantinova.ai

TCT170 : Safety and efficacy of bivalirudin during percutaneous intervention in acute coronary syndrome in the real world. The CARTAGOMAX study

Researchers

Presenter

  • Jose D. Cascon

Principal Investigators

  • Jose Abellan-Huerta

  • Tamara Archondo-Arce

  • Miryam Martinez-Pascual-de-Riquelme

  • Irene-Azenaia Garcia-Escribano-Garcia

  • Santiago Sanchez-Argente-del-Castillo

  • F. Guillermo Clavel-Ruiperez

  • Pablo Ramos-Ruiz

  • Maria-Lucia Fernandez-Gasso

  • Erika Munoz-Garcia

  • Juan A. Castillo-Moreno

Medical Centers

  • Hospital de Santa Lucia, Cartagena, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Acute Coronary Syndromes

  • Venous thrombosis

  • Stroke

Biomarkers

  • Glycosylphosphatidylinositol

Drug/Treatment

  • Bivalirudin

  • Clopidogrel bisulfate

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved